Peroxovanadium compounds: Biolgoical actions and mechanism of insulin-mimesis
Open Access
- 1 January 1995
- journal article
- review article
- Published by Springer Science and Business Media LLC in Molecular and Cellular Biochemistry
- Vol. 153 (1-2), 49-58
- https://doi.org/10.1007/bf01075918
Abstract
When used alone, both vanadate and hydrogen peroxide (H_2O_2) are weakly insulin-mimetic, while in combination they are strongly synergistic due to the formation of aqueous peroxovanadium species pV_(aq). Administration of these pV_(aq) species leads to activation of the insulin receptor tyrosine kinase (IRK), autophosphorylation at tyrosine residues and inhibition of phosphotyrosine phosphatases (PTPs). We therefore undertook to synthesize a series of peroxovanadium (pV) compounds containing one or two peroxo anions, an oxo anion and an ancillary ligand in the inner co-ordination sphere of vanadium, whose properties and insulin-mimetic potencies could be assessed. These pV compounds were shown to be the most potent inhibitors of PTPs yet described. Their PTP inhibitory potency correlated with their capacity to stimulate IRK activity. Some pV compounds showed much greater potency as inhibitors of insulin receptor (IR) dephosphorylation than epidermal growth factor receptor (EGFR) dephosphorylation, implying relative specificity as PTP inhibitors. Replacement of vanadium with either molybdenum or tungsten resulted in equally potent inhibition of IR dephosphorylation. However IRK activation was reduced by greater than 80% suggesting that these compounds did not access intracellular PTPs. The insulin-like activity of these pV compounds were demonstrable in vivo. Intra venous (i.v.) administration of bpV(pic) and bpV(phen) resulted in the lowaring of plasma glucose concentrations in normal rats in a dose dependent manner. The greater potency of bpV(pic) compared to bpV(phen) was explicable, in part, by the capacity of the former but not the latter to act on skeletal muscle as well as liver. Finally administration of bpV(phen) and insulin led to a synergism, where tyrosine phosphorylation of the IR β-subunit increased by 20-fold and led to the appearance of four insulin-dependent in vivo substrates. The insulin-mimetic properties of they pV compounds raises the possibility for their use as insulin replacements in the management of diabetes mellitus.Keywords
This publication has 51 references indexed in Scilit:
- Hepatic tyrosine-phosphorylated proteins identified and localized following in vivo inhibition of protein tyrosine phosphatases: effects of H2O2 and vanadate administration into rat liversMolecular and Cellular Endocrinology, 1993
- Pharmacological doses of insulin equalize insulin receptor phosphotyrosine content but not tyrosine kinase activity in plasmalemmal and endosomal membranesBiochemistry and Cell Biology, 1992
- A combination of hydrogen peroxide and vanadate concomitantly stimulates protein tyrosine phosphorylation and polyphosphoinositide breakdown in different cell linesBiochemistry, 1990
- Vasopressin, insulin and peroxide(s) of vanadate (pervanadate) influence Na+ transport mediated by (Na+, K+)ATPase or Na+/H+ exchanger of rat liver plasma membrane vesiclesEuropean Journal of Biochemistry, 1990
- Protein-tyrosine phosphorylation and aggregation of intact human platelets by vanadate with H2O2Biochemical and Biophysical Research Communications, 1990
- Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinaseBiochemistry, 1989
- Peroxide(s) of vanadium : A novel and potent insulin-mimetic agent which activates the insulin receptor kinaseBiochemical and Biophysical Research Communications, 1987
- Vanadate stimulation of IGF binding to rat adipocytesBiochemical and Biophysical Research Communications, 1986
- Effect of Vanadate on Elevated Blood Glucose and Depressed Cardiac Performance of Diabetic RatsScience, 1985
- Effects of vanadium on glucose metabolism in vitroLife Sciences, 1979